DR. JOSEPH BLAISE GUARNACCIA, M.D.
Neurology at Division St, Derby, CT

License number
Connecticut 031179
Category
Neurology
Type
Neurology
License number
Connecticut 1045N
Category
Neurology
Type
Neurology
Address
Address 2
130 Division St FLOOR 1ST, Derby, CT 06418
137 Cold Spring St, New Haven, CT 06511
Phone
(203) 732-1290
(203) 732-1299 (Fax)
(203) 776-4223

Professional information

Joseph B Guarnaccia Photo 1

Dr. Joseph B Guarnaccia, Derby CT - MD (Doctor of Medicine)

Specialties:
Internal Medicine, Neuropsychiatry (Neurology)
Address:
Multiple Sclerosis Treatmnt Ctr
130 Division St, Derby 06418
(203) 732-1290 (Phone)
MS Center Of Care New England
1351 S County Trl STE 200, East Greenwich 02818
(401) 886-0629 (Phone)
Certifications:
Internal Medicine, 1990, Neurology, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Multiple Sclerosis Treatmnt Ctr
130 Division St, Derby 06418
MS Center Of Care New England
1351 S County Trl STE 200, East Greenwich 02818
Griffin Hospital
130 Division St, Derby 06418
Education:
Medical School
University of Oklahoma / Health Sciences Center
Graduated: 1987


Joseph Blaise Guarnaccia Photo 2

Joseph Blaise Guarnaccia, Derby CT

Specialties:
Neurologist
Address:
130 Division St, Derby, CT 06418
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)


Joseph Guarnaccia Photo 3

Joseph Guarnaccia, Derby CT

Work:
Griffin Hospital
130 Division St, Derby, CT 06418 Kent County Hospital
455 Toll Gate Rd, Warwick, RI 02886 MS Center of Care New England
1351 S County Trl, East Greenwich, RI 02818


Joseph Guarnaccia Photo 4

Daptomycin For Multiple Sclerosis

US Patent:
2012020, Aug 9, 2012
Filed:
Sep 2, 2010
Appl. No.:
13/395369
Inventors:
Joseph B. Guarnaccia - Derby CT, US
International Classification:
A61K 38/12, A61P 21/00, A61P 25/00
US Classification:
514 179, 514 177, 514 211
Abstract:
Compounds and compositions, and methods of use thereof, for treatment and/or prevention of multiple sclerosis, including symptoms associated with multiple sclerosis, and/or treatment and/or prevention of other disease/disorder affecting the nervous system (e.g. central, peripheral) or muscle including symptoms thereof, comprising administering to a subject in need thereof daptomycin and/or daptomycin-related lipopeptide.